Skip to main content
Top
Published in: Clinical Rheumatology 10/2016

01-10-2016 | Letter to the Editor

Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.

Authors: Bahtiyar Toz, Burak Erer

Published in: Clinical Rheumatology | Issue 10/2016

Login to get access

Excerpt

We read with interest the review entitled “Rheumatologic manifestations of primary immunodeficiency diseases” by Dimitriades et al. [1]. This is a well-written review providing guidance for rheumatologists regarding when they should consider primary immunodeficiency diseases and also explores how these immunodeficiency states may be underlying their rheumatologic disorder. We would like to comment on this review regarding other associations between rheumatologic disorders and primary immunodeficiency diseases. …
Literature
1.
go back to reference Dimitriades VR, Sorensen R (2016) Rheumatologic manifestations of primary immunodeficiency diseases. Clin Rheumatol 35(4):843–50CrossRefPubMed Dimitriades VR, Sorensen R (2016) Rheumatologic manifestations of primary immunodeficiency diseases. Clin Rheumatol 35(4):843–50CrossRefPubMed
2.
go back to reference Giannelou A, Zhou Q, Kastner DL (2014) When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol 14(6):491–500CrossRefPubMedPubMedCentral Giannelou A, Zhou Q, Kastner DL (2014) When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol 14(6):491–500CrossRefPubMedPubMedCentral
3.
go back to reference De Jesus AA, Canna SW, Liu Y et al (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–74CrossRefPubMedPubMedCentral De Jesus AA, Canna SW, Liu Y et al (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–74CrossRefPubMedPubMedCentral
Metadata
Title
Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.
Authors
Bahtiyar Toz
Burak Erer
Publication date
01-10-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 10/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3293-y

Other articles of this Issue 10/2016

Clinical Rheumatology 10/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.